- Research Article
- Open Access
Blue Laser Light Increases Perfusion of a Skin Flap Via Release of Nitric Oxide from Hemoglobin
- Rainer Mittermayr†1,
- Anatoly Osipov†2,
- Christina Piskernik1,
- Susanne Haindl1,
- Peter Dungel1,
- Carina Weber1,
- Yuri A. Vladimirov2,
- Heinz Redl1 and
- Andrey V. Kozlov1Email author
© Feinstein Institute for Medical Research 2007
- Received: 2 May 2006
- Accepted: 16 November 2006
- Published: 1 January 2007
It has recently been shown that nitrosyl complexes of hemoglobin (NO-Hb) are sensitive to low-level blue laser irradiation, suggesting that laser irradiation can facilitate the release of biologically active nitric oxide (NO), which can affect tissue perfusion. The aim of this study was to evaluate the therapeutic value of blue laser irradiation for local tissue perfusion after surgical intervention. Blood was withdrawn from a rat, exposed to NO and infused back to the same rat or used for in vitro experiments. In vitro, an increase of NO-Hb levels (electron paramagnetic resonance spectroscopy) up to 15 µM in rat blood did not result in the release of detectable amounts of NO (NO selective electrode). Blue laser irradiation of NO-Hb in blood caused decomposition of NO-Hb complexes and release of free NO. Systemic infusion of NO-Hb in rats affected neither systemic circulation (mean arterial pressure) nor local tissue perfusion (Doppler blood flow imaging system). In contrast, a clear enhancement of local tissue perfusion was observed in epigastric flap when elevated NO-Hb levels in blood were combined with local He-Cd laser irradiation focused on the left epigastric artery. The enhancement of regional tissue perfusion was not accompanied by any detectable changes in systemic circulation. This study demonstrates that blue laser irradiation improves local tissue perfusion in a controlled manner stimulating NO release from NO-Hb complexes.
Decreased peripheral blood flow related to impaired microcirculatory vasodilatation has been shown to occur in certain disease states including peripheral vascular disease, diabetes mellitus, hypercholesterolemia, hypertension, chronic renal failure, abdominal aortic aneurysmal disease, and venous insufficiency, as well as in menopause, advanced age, and obesity (1). Impaired peripheral blood flow appears also as a serious complication of transplantation (2) and plastic surgery (3), often resulting in transplant loss. Nitric oxide (NO) is one of the most important physiological regulators of the microcirculation (4–7), which activates vasodilatation via activation of cGMP-dependent pathway (8). The main source of NO for vasodilatation is the endothelial NO synthase (eNOS). The expression of this enzyme is regulated by a range of transcriptional and posttranscriptional mechanisms generating NO in response to a number of stimuli (9). However, in pathological states (i.e., ischemia) the generation of NO by eNOS is often impaired (10). NO donors as a source of exogenous NO have been shown to improve ischemia/reperfusion injury (11). In blood, NO reacts quickly with Hb. This interaction follows two pathways, namely NO-mediated oxidation of oxyHb to methemoglobin yielding NO3− and, secondly, the binding of NO to Hb yielding nitrosyl complexes of hemoglobin (NO-Hb). Both reactions have very high rate constants, 3.7 × 107 M−1 s−1 and 2.6 × 107 M−1 s−1, respectively (12), suggesting that under physiological conditions, there is no free NO in blood. Gow and coauthors (12,13), however, have shown that oxygen drives the conversion of nitrosylhemoglobin to S-nitrosohemoglobin (SNO-Hb), which was suggested to act as an endogenous NO donor and physiological regulator of blood pressure, releasing NO (14). Other data, however, suggest that SNO-Hb is not stable enough and releases nitrate (15), rather than turning back to NO-Hb. Despite these conflicting data on the role of SNO-Hb, the NO-Hb complexes are not considered to be a source of NO due to very high affinity of NO to heme iron.
A few years ago it was shown that NO-Hb complexes in protein solution are photosensitive and can release NO during exposure to laser radiation (16,17). Two years later it was shown that the exposure of smooth muscle to UV and visible light facilitates muscle relaxation and NO was supposed to be a mediator of this relaxation (18). The aim of this study was to clarify whether photo-dissociation of NO-Hb following vasodilatation can be a vasodilatory mechanism in in vivo systems. We have chosen a skin flap model for in vivo testing of this mechanism. Obligatory period of ischemia is an important problem in flap surgery and microcirculation was expected to improve.
The Animal Protocol Review Board of Vienna City Government approved the experimental protocol. All experimental procedures were performed under the conditions described in the guide for the care and use of laboratory animals of the National Institute of Health (publication NIH 86–23, revised 1985). Male Sprague Dawley rats (mean weight 397 g ±17 SD) were initially anesthetized in an inhalation box provided with isoflurane (1.5–2.5 Vol%), oxygen (300 mL/min), nitrous oxide (750 mL/min), and air (3 L/min). Thereafter animals were transferred to a temperature-controlled surgical plate (rectal body temperature was maintained between 37.0 and 37.8°C). Anesthesia was maintained via an inhalation mask with the same scheme of anesthesia as mentioned above. Then the entire abdomen and the cervical region were carefully shaved followed by depilation. In all animals the jugular vein was cannulated and 1 mL/h of Ringer’s solution was administered for fluid substitution and to maintain a constant blood pressure. A small incision in the right groin provided access to the right femoral artery, which was also cannulated. The catheter introduced in the femoral artery was used to withdraw the blood, to monitor systemic blood pressure, and as the port for administering the NO-Hb preparation. Later the incision was sutured using the interrupted sewing technique. Systemic mean arterial pressure (MAP) was measured with a Cardiosys (Ex-perimetria, Hungary).
Enriching RBC and Whole Blood with NO-Hb Complexes
NO-Hb Detection by EPR
Determination of NO-Hb levels was performed in RBC and whole blood withdrawn from the right femoral vein after bolus infusion of either NO-Hb solution or control solution, and whole blood from the right femoral artery after HeCd laser irradiation again for both groups. The concentrations of nitrosylhe-moglobin complexes in blood samples were measured by means of electron paramagnetic resonance (EPR) spectroscopy. Blood samples were placed in 1 mL syringes, frozen and stored at liquid nitrogen temperature until use. For measurement, samples were pressed out of the syringes and moved to a finger-tip liquid nitrogen Dewar. EPR spectra were recorded on a Bruker EMX EPR spectrometer (BioSpin GmbH Rheinstetten/Karlsruhe, Germany) at liquid nitrogen temperature under the following settings: microwave frequency 9,429 GHz, microwave power 30 mW, modulation frequency 100 kHz, modulation amplitude 6 G. For quantification of NO-Hb levels in blood samples, NO-Hb standards were prepared using NO2− solutions reduced by dithionite in the presence of hemoglobin as described before (29). Briefly, 100 mg of dithionite were mixed with 300 µL Hb and a range of NO2− concentrations (0 to 10 µM). The nitrosyl-hemoglobin signals in blood were compared with the standard solutions.
NO Detection by NO-Electrode
To evaluate the amount of free NO in suspension of RBC or blood containing NO-Hb, erythrocytes or whole blood enriched with NO-Hb were introduced into the NO-electrode measuring chamber (NO-chamber, WPI, USA). To remove air oxygen from the samples, gaseous nitrogen was bubbled through the buffer for 15 min before NO solution and RBC/blood were added. The samples were irradiated with laser light through the channel made in a NO-chamber for the second electrode. The calibration procedure was made in accordance with manufacturer instructions. To create a calibration curve, 20 µL of 50 µM NaNO2 was added to 10 mL calibration solution (0,1 M H2SO4 + 0,1 M KI). This was repeated 3 times to show the stability of the NO electrode.
Axial Epigastric Flap
To observe the effect of NO-Hb and laser irradiation on vasomotility (vasodilatation) we chose to use the axial epigastric flap model. This model provides the possibility to exclude the influence of surrounding arterial inflow, studying only the definite inferior epigastric vessel tree. The dimensions of the flap were the same in all animals (4 × 8 cm2) whereas the position of the flap varied according to the entrance of the left epigastric artery into the flap. The flap borders were outlined with a surgical marker. Surgical flap harvesting was performed cranially to caudally by blunt dissection technique. The entire flap was attached only left to the inferior epigastric neurovascular bundle. The fasciomy-ocutaneous flap was then sutured back to its original anatomical orientation with non-resorbable sutures using interrupted technique. The caudal incision of the flap was partly left open to ensure easy access to the left inferior epigastric artery for laser irradiation.
Superficial Perfusion Measurement
The Laser Doppler Imaging System (Moor, UK) was used to illustrate and evaluate flap perfusion. A low intensity (2mW) laser light beam (wavelength of 632.8nm) was scanned across the surface of the skin in a raster fashion by a moving mirror, thus giving a two-dimensional image of flap perfusion. Laser beam movements without any skin contact came from a standard working distance of 20 cm. Scan modus was set at 10 ms/pixel, and a resolution of 256 × 256 pixels was chosen. Perfusion values were recorded as colored pixels, giving the color-coordinated 2-D image of the flap perfusion. Three scans each lasting 4 min were acquired for each phase of experiments. The first phase, background, started 30 min after flap harvesting. During NO-Hb/saline bolus and infusion (Infusion phase), again three scans each lasting 4 min were acquired. The same scan protocol was used for the irradiation period (Irradiation phase) as well as for the period after irradiation (Post Irradiation phase). The laser beam was focused through the small caudal incision on the left epigastric artery directly distal to the origin from the femoral artery. Acquired images were further processed and evaluated with an image analyzing software tool, provided by the manufacturer of the LDI system. Numeric results were calculated in percentage of perfusion units (%PU). The mean of the three scans in the baseline period was set at 100%. The single baseline scans as well as the subsequent scans are referred to this mean baseline and expressed as percentage of mean baseline.
Whole blood samples were diluted in ethanol 1:3 (w/w) and put on ice for 30 min. Diluted ethanol/sodium chloridesolution 2:1 (volume/volume) was added to the diluted blood samples so that the final dilution of the samples in ethanol was 1:10.
After this procedure, the samples were mixed, centrifuged, and the supernatant was used for cGMP measurements via enzymimmunoassay. The determination procedure was carried out in accordance to manufacturer instructions, protocol #2 (c-GMP Enzymimmunoassay Biotrak (EIA) System, Amersham Biosciences Europe GmbH, Freiburg, Germany).
All data are presented as means ± SEM. Statistical analysis for in vitro experiments was performed by two-tailed Student test and for in vivo experiments using oneway ANOVA test followed by post hoc test for least significant difference (LSD). Significance was based on a value of P < 0.05. The calculations were made with the software MS Excel (Microsoft Corp.) and SPSS 11.5 for Windows (SPSS Inc.).
Interaction between NO-Hb Complexes and Laser Irradiation
Addition of NO solution to the chamber containing buffer results in a quick rise of the NO levels followed by a decay of NO levels, likely due to interaction with medium components and residues of oxygen. Addition of RBC results in an immediate disappearance of NO from the medium (Figure 1A). Thereafter a signal characteristic for NO-Hb was determined in the sample (Figure 1B). The same signal can be detected if whole blood is used instead of RBC (data not presented). He-Cd laser irradiation applied to the sample resulted in an increase in NO levels as detected by electrode technique (Figure 1A, inset) and in a decay of NO-Hb EPR signal (Figure 1C).
Effect of laser irradiation on the integral intensity and features of NO-Hb signal in RBC suspension enriched with NO.
Sets of samples (AU)
Incubation without laser (s)
Incubation under laser (s)
Integral intensity of NO-Hb signal (AU)
The ratio of EPR signal features of 5 to 6 coordinated NO-Hb
100.0 ± 1.0
0.46 ± 0.07
99.8 ± 0.7
0.42 ± 0.04
97.0* ± 1.38
94.0* ± 2.25
90.1* ± 0.35
0.26* ± 0.03
Effect of NO-Hb Infusion on Parameters of the Systemic Circulation
Effect of NO-Hb Infusion Combined with Laser Irradiation on Parameters of the Systemic Circulation
Effect of NO-Hb Infusion Combined with Laser Irradiation on the Local Tissue Perfusion
Interaction of NO-Hb and Laser in Vitro
It has been previously shown that laser irradiation can induce dissociation of NO-Hb complexes in pure protein solution (16,17). In this study we have shown that this process can be induced also in RBC suspension (Figure 1,2). Moreover we have demonstrated that NO released from NO-Hb by laser can escape RBC. This was confirmed by detection of NO with NO-electrode in RBC medium and in blood. We have also shown that the release of NO is a reversible process, which takes place only under laser irradiation. After irradiation was accomplished, the levels of NO quickly decayed to undetectable levels. Because EC50 of guanylyl cyclase is approx. 2 nM (19), which is below the detection limit of the NO-electrode, it is not presumed that the remaining NO can not alter circulation systemically. The data presented in Table 1 show that irradiation influences the 5-coordinate iron nitrosyl complexes. 5-coordinate Fe(II)NO moieties is a signature of the T-state conformation, which does not lead to formation of SNO-Hb (7). This is an important point because it suggests that laser irradiation facilitates the release of NO from nitrosyl complexes of hemoglobin rather than the formation of S-nitroso-hemoglobin prior to NO release.
Effect of NO-Hb Infusion and Laser Irradiation on Systemic Circulation
We did not observe a decrease in MAP upon addition of NO-Hb, in spite of Gladwin et al (20) recently reporting a direct NO release from heme. However, looking just at Figure 5, a trend to lower blood pressure in animals receiving NO-Hb is seen. This trend could probably become significant with increasing NO-Hb levels. In such a situation NO-Hb complexes may influence systemic circulation, but this was not a focus of the present study. Nevertheless, this shows a compelling possibility to influence both systemic blood pressure and local tissue perfusion by means of infusion of NO-Hb. To clarify the question of whether photodissociation of NO-Hb can contribute to systemic circulation, we have chosen a model of skin flap perfusion, which makes possible a precise irradiation of the epigastric artery. In the experiments with flap perfusion, we have shown that neither infusion of NO-Hb nor infusion of NO-Hb combined with laser irradiation decreases blood pressure or elevates cGMP levels in circulating blood (Figure 3). Stable blood pressure indicates that spontaneous NO liberation from nitrosyl-hemoglobin does not occur in vivo, which is in line with recently published data (21). In contrast to unaltered MAP and cGMP levels, the concentration of NO-Hb complexes in blood decreased in response to laser irradiation. This indicates that NO is released from Hb but does not contribute to systemic circulation, probably due to the short lifetime of this molecule. However, it can be assumed that NO released from NO-Hb is able to influence the local circulation.
Effects of NO-Hb Infusion and Laser Irradiation on Local Circulation
We expected that the effect of laser irradiation should be limited to a small area in the vicinity of the irradiation point. Therefore we followed local circulation in the flap before and after laser irradiation by means of an LDI system. Neither infusion of NO-Hb alone, nor laser irradiation without NO-Hb infusion, did not influence local circulation. Only a combination of NO-Hb infusion and laser irradiation resulted in a remarkable increase of blood flow. We observed the main effect of epigastric artery irradiation directly distal to the laser focus. This indicates a targeted and strictly local limited irradiation effect, which can explain the unchanged cGMP levels in systemic circulation. Locally produced cGMP was simply diluted in systemic blood to undetectable concentrations. Our data suggest that laser irradiation induces the release of NO from nitrosyl complexes of hemoglobin followed by increased perfusion of the tissue. However, we do not know the precise mechanism(s) underlying this effect. One could consider two possibilities. The first is that released NO diffuses to the vessel wall and induces vasodilatation. Another possible mechanism is recently reported in a series of publications of Marc Gladwin et al. considering nitrite as an intermediate in such a signaling pathway (20,22,23). It is difficult to say which of those pathways is operating predominantly in our experimental model; it is likely dependendent on many factors, primarily oxygen levels, which facilitate formation of nitrite from NO.
Possible Medical Applications
Our study clearly shows an increased local superficial flap perfusion by single spot irradiation using He-Cd laser combined with NO-Hb infusion. The perfusion area can be located precisely by positioning the laser beam on a corresponding blood vessel. In addition, the perfusion time can be determined exactly by turning the laser on and off. Thus, this study provides a new approach to improve local blood supply in a controlled manner, by local laser irradiation inducing NO release from NO-Hb complexes. This is the first report on an approach to regulate tissue perfusion in a precisely selected part of the body, which does not interfere with systemic blood circulation. The indications for such treatment can be flap surgery (pre-, post-surgery), non-surgical delay strategies or impaired blood supply in problematic superficial regions (chronic ulcers). In this study we infused exogenous NO-Hb complexes into control rats. However, these complexes can appear in the circulation, deriving from endogenous sources of NO. Therefore, it can be expected that under pathological circumstances, the effect of laser irradiation can occur without infusing NO-Hb. Such applications of laser irradiation are known as low level laser therapy (24–28).
Contribution to Low-Level Laser Therapy
Low-level laser therapy (LLLT) has received particular attention during the last decade. It has been reported to facilitate wound healing (24), particular venous leg ulcers (25), improve pain relief (26,27), rheumatoid arthritis (28) and a number of other disorders. However, recent attempts to review the results of LLLT have shown large variations in results due to a large heterogeneity of patients (26) and the absence of clear rules on how to choose the right irradiation conditions (28). At present, there are only empiric methods to choose the settings of LLLT. There is no objective method for immediate monitoring of the efficiency of LLLT and therefore little knowledge about mechanisms underlying LLLT is available. Our study shows that the photodissociation of NO-Hb may be a mechanism underlying effects of laser irradiation. This study provides a new approach to improve local blood supply in a controlled manner, by local laser irradiation-induced NO release from NO-Hb complexes. This is the 1st report on an approach to regulate tissue perfusion in a precisely selected part of the body which does not interfere with systemic blood circulation.
To Prof. S. Bahrami, Dr. K. Moser, Dr. A. Schultz for stimulating discussions of the results, to Kathrin Reise for assistance in a number of experiments, to Tricia Behling for final editing of the manuscript, and to the Russian Foundation for Basic Research, grant # 03-04-48891.
- Abularrage CJ et al. (2005) Evaluation of the microcirculation in vascular disease. J. Vasc. Surg. 42:574–81.View ArticleGoogle Scholar
- Menger MD, Vollmar B. (2000) Role of microcirculation in transplantation. Microcirculation. 7:291–306.View ArticleGoogle Scholar
- Langer S et al. (2004) Importance of microcirculation in plastic surgery. Handchir. Mikrochir. Plast. Chir 36:197–204.View ArticleGoogle Scholar
- Moncada S, Palmer RM, Higgs EA. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109–42.PubMedGoogle Scholar
- Dusting GJ. (1995) Nitric oxide in cardiovascular disorders. J. Vasc. Res. 32:143–61.View ArticleGoogle Scholar
- Ito S, Carretero OA, Abe K. (1997) Role of nitric oxide in the control of glomerular microcirculation. Clin. Exp. Pharmacol. Physiol. 24:578–81.View ArticleGoogle Scholar
- Singel DJ, Stamler JS. (2005) Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. Annu. Rev. Physiol. 67:99–145.View ArticleGoogle Scholar
- Palmer RM, Ferrige AG, Moncada S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524–6.View ArticleGoogle Scholar
- Fleming I, Busse R. (2003) Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am. J. Physiol Regul. Integr. Comp. Physiol. 284:R1–12.View ArticleGoogle Scholar
- Huk I et al. (1997) L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 96:667–75.View ArticleGoogle Scholar
- Mittermayr R et al. (2003) Protective effect of a novel NO-donor on ischemia/reperfusion injury in a rat epigastric flap model. Wound Repair Regen. 11:3–10.View ArticleGoogle Scholar
- Gow AJ, Luchsinger BP, Pawloski JR, Singel DJ, Stamler JS. (1999) The oxyhemoglobin reaction of nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 96:9027–32.View ArticleGoogle Scholar
- Gow AJ; Stamler JS. (1998) Reactions between nitric oxide and hemoglobin under physiological conditions. Nature 391:169–73.View ArticleGoogle Scholar
- Wolzt M et al. (1999) Biochemical characterization of S-nitrosohemoglobin — Mechanisms underlying synthesis, no release, and biological activity. J. Biol. Chem. 274:28983–90.View ArticleGoogle Scholar
- Gladwin MT et al. (2002) S-Nitrosohemoglobin is unstable in the reductive erythrocyte environment and lacks O2/NO-linked allosteric function. J. Biol. Chem. 277:27818–28.View ArticleGoogle Scholar
- Borisenko GG, Osipov AN, Kazarinov KD, Vladimirov YuA. (1997) Photochemical reactions of nitrosyl hemoglobin during exposure to low-power laser irradiation. Biochemistry Mosc. 62:661–6.PubMedGoogle Scholar
- Vladimirov Y, Borisenko G, Boriskina N, Kazarinov K, Osipov A. (2000) NO-hemoglobin may be a light-sensitive source of nitric oxide both in solution and in red blood cells. J. Photochem. Photobiol. B 59:115–22.View ArticleGoogle Scholar
- Flitney FW, Megson IL. (2003) Nitric oxide and the mechanism of rat vascular smooth muscle photorelaxation. J Physiol. 550:819–28.View ArticleGoogle Scholar
- Bellamy TC, Griffiths C, Garthwaite J. (2002) Differential sensitivity of guanylyl cyclase and mitochondrial respiration to nitric oxide measured using clamped concentrations. J. Biol. Chem. 277:31801–7.View ArticleGoogle Scholar
- Gladwin MT et al. (2000) Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc. Natl. Acad. Sci. U. S. A 97:11482–7.View ArticleGoogle Scholar
- Kozlov AV et al. (2005) Mechanisms of vasodilatation induced by nitrite instillation in intestinal lumen: possible role of hemoglobin. Antioxid. Redox. Signal. 7:515–21.View ArticleGoogle Scholar
- Gladwin MT, Crawford JH, Patel RP. (2004) The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radic. Biol. Med. 36:707–17.View ArticleGoogle Scholar
- Cosby K et al. (2003) Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med. 9:1498–505.View ArticleGoogle Scholar
- Posten W et al. (2005) Low-level laser therapy for wound healing: mechanism and efficacy. Dermatol. Surg. 31:334–40.View ArticleGoogle Scholar
- Flemming KA, Cullum NA, Nelson EA. (1999) A systematic review of laser therapy for venous leg ulcers. J. Wound. Care 8:111–4.View ArticleGoogle Scholar
- Bjordal JM, Couppe C, Chow RT, Tuner J, Ljunggren EA. (2003) A systematic review of low level laser therapy with location-specific doses for pain from chronic joint disorders. Aust. J. Physiother. 49:107–16.View ArticleGoogle Scholar
- Sun G; Tuner J. (2004) Low-level laser therapy in dentistry. Dent. Clin. North Am. 48:1061–76, viii.View ArticleGoogle Scholar
- Brosseau L et al. (2000) Low level laser therapy (classes I, II and III) in the treatment of rheumatoid arthritis. Cochrane Database Syst. Rev. CD002049.Google Scholar
- Kozlov AV, Dietrich B, Nohl H. (2003) Various intracellular compartments cooperate in the release of nitric oxide from glycerol trinitrate in liver. Br. J. Pharmacol. 139:989–97.View ArticleGoogle Scholar